Alan L Rotman
Examiner (ID: 15220)
Most Active Art Unit | 1201 |
Art Unit(s) | 1802, 1612, 1201, 1203, 2899, 1625 |
Total Applications | 2275 |
Issued Applications | 1794 |
Pending Applications | 68 |
Abandoned Applications | 413 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18351255
[patent_doc_number] => 20230139366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => BRARTEMICIN ANALOGUES
[patent_app_type] => utility
[patent_app_number] => 18/047708
[patent_app_country] => US
[patent_app_date] => 2022-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27175
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18047708
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/047708 | BRARTEMICIN ANALOGUES | Oct 18, 2022 | Pending |
Array
(
[id] => 18162015
[patent_doc_number] => 20230028607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => COMPOSITIONS AND METHODS THAT ATTENUATE COGNITIVE AGING IN INDIVIDUALS WHO DO NOT HAVE DEMENTIA
[patent_app_type] => utility
[patent_app_number] => 17/960966
[patent_app_country] => US
[patent_app_date] => 2022-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7548
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17960966
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/960966 | COMPOSITIONS AND METHODS THAT ATTENUATE COGNITIVE AGING IN INDIVIDUALS WHO DO NOT HAVE DEMENTIA | Oct 5, 2022 | Pending |
Array
(
[id] => 18339918
[patent_doc_number] => 20230131867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => TRITERPENE SAPONINS, METHODS OF SYNTHESIS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/947716
[patent_app_country] => US
[patent_app_date] => 2022-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38692
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17947716
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/947716 | TRITERPENE SAPONINS, METHODS OF SYNTHESIS AND USES THEREOF | Sep 18, 2022 | Pending |
Array
(
[id] => 18518506
[patent_doc_number] => 11708386
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => Ultrasonic-microwave synergistic extraction method of total saponins in beautiful millettia root
[patent_app_type] => utility
[patent_app_number] => 17/946531
[patent_app_country] => US
[patent_app_date] => 2022-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4005
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 378
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17946531
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/946531 | Ultrasonic-microwave synergistic extraction method of total saponins in beautiful millettia root | Sep 15, 2022 | Issued |
Array
(
[id] => 18254107
[patent_doc_number] => 20230081146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => METHODS AND COMPOSITIONS TO PREVENT AND TREAT INFLAMMATION AND ALLERGIC REACTIONS
[patent_app_type] => utility
[patent_app_number] => 17/931491
[patent_app_country] => US
[patent_app_date] => 2022-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21214
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17931491
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/931491 | METHODS AND COMPOSITIONS TO PREVENT AND TREAT INFLAMMATION AND ALLERGIC REACTIONS | Sep 11, 2022 | Pending |
Array
(
[id] => 18299334
[patent_doc_number] => 20230109020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => Nucleic Acid and Other Compositions and Methods for the Modulation of Cell Membranes
[patent_app_type] => utility
[patent_app_number] => 17/941835
[patent_app_country] => US
[patent_app_date] => 2022-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21955
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17941835
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/941835 | Nucleic Acid and Other Compositions and Methods for the Modulation of Cell Membranes | Sep 8, 2022 | Pending |
Array
(
[id] => 18034522
[patent_doc_number] => 20220378737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => TREATMENT OF METABOLIC DISORDERS IN CANINE ANIMALS
[patent_app_type] => utility
[patent_app_number] => 17/873638
[patent_app_country] => US
[patent_app_date] => 2022-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16495
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17873638
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/873638 | TREATMENT OF METABOLIC DISORDERS IN CANINE ANIMALS | Jul 25, 2022 | Pending |
Array
(
[id] => 18177133
[patent_doc_number] => 20230037862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => SYNTHETIC AGONISTS OF TLR4 RECEPTOR
[patent_app_type] => utility
[patent_app_number] => 17/813140
[patent_app_country] => US
[patent_app_date] => 2022-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7478
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17813140
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/813140 | SYNTHETIC AGONISTS OF TLR4 RECEPTOR | Jul 17, 2022 | Pending |
Array
(
[id] => 18125056
[patent_doc_number] => 20230010671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-12
[patent_title] => PROTON ACTIVATED ATOMIC MEDICINE
[patent_app_type] => utility
[patent_app_number] => 17/850467
[patent_app_country] => US
[patent_app_date] => 2022-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18538
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17850467
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/850467 | PROTON ACTIVATED ATOMIC MEDICINE | Jun 26, 2022 | Pending |
Array
(
[id] => 17851812
[patent_doc_number] => 20220281854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => COMBINATION THERAPY FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/751153
[patent_app_country] => US
[patent_app_date] => 2022-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38779
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 291
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17751153
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/751153 | COMBINATION THERAPY FOR TREATING CANCER | May 22, 2022 | Pending |
Array
(
[id] => 17790445
[patent_doc_number] => 20220249536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => ANTIBODY DRUG CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 17/730924
[patent_app_country] => US
[patent_app_date] => 2022-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27723
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17730924
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/730924 | Antibody drug conjugates | Apr 26, 2022 | Issued |
Array
(
[id] => 17807418
[patent_doc_number] => 20220259253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => CD73 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/722513
[patent_app_country] => US
[patent_app_date] => 2022-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74599
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -123
[patent_words_short_claim] => 1087
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17722513
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/722513 | CD73 INHIBITORS | Apr 17, 2022 | Pending |
Array
(
[id] => 17944333
[patent_doc_number] => 20220331350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => METHODS FOR TREATMENT AND PROPHYLAXIS OF HIV AND AIDS
[patent_app_type] => utility
[patent_app_number] => 17/658547
[patent_app_country] => US
[patent_app_date] => 2022-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9732
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17658547
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/658547 | METHODS FOR TREATMENT AND PROPHYLAXIS OF HIV AND AIDS | Apr 7, 2022 | Pending |
Array
(
[id] => 17670944
[patent_doc_number] => 20220184111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY
[patent_app_type] => utility
[patent_app_number] => 17/682655
[patent_app_country] => US
[patent_app_date] => 2022-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22680
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17682655
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/682655 | METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY | Feb 27, 2022 | Pending |
Array
(
[id] => 18109631
[patent_doc_number] => 20230002511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => HIGH-VISCOSITY LITHIUM CARBOXYMETHYL CELLULOSE AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/681971
[patent_app_country] => US
[patent_app_date] => 2022-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5124
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17681971
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/681971 | High-viscosity lithium carboxymethyl cellulose and preparation method therefor and application thereof | Feb 27, 2022 | Issued |
Array
(
[id] => 17687687
[patent_doc_number] => 20220194979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => METHOD FOR PREPARING DELPHINIUM ACYLATED ANTHOCYANIN
[patent_app_type] => utility
[patent_app_number] => 17/674860
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4226
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 346
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17674860
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/674860 | Method for preparing delphinium acylated anthocyanin | Feb 17, 2022 | Issued |
Array
(
[id] => 17642270
[patent_doc_number] => 20220170008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => POLYNUCLEOTIDE CAPTURE MATERIALS, AND SYSTEMS USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/674177
[patent_app_country] => US
[patent_app_date] => 2022-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13472
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17674177
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/674177 | POLYNUCLEOTIDE CAPTURE MATERIALS, AND SYSTEMS USING SAME | Feb 16, 2022 | Pending |
Array
(
[id] => 18091303
[patent_doc_number] => 20220409644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/674032
[patent_app_country] => US
[patent_app_date] => 2022-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50421
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17674032
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/674032 | ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE | Feb 16, 2022 | Pending |
Array
(
[id] => 19441229
[patent_doc_number] => 12091470
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-17
[patent_title] => Use of poly alpha-1,3-glucan ethers as viscosity modifiers
[patent_app_type] => utility
[patent_app_number] => 17/667707
[patent_app_country] => US
[patent_app_date] => 2022-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36004
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17667707
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/667707 | Use of poly alpha-1,3-glucan ethers as viscosity modifiers | Feb 8, 2022 | Issued |
Array
(
[id] => 17865361
[patent_doc_number] => 20220288096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER
[patent_app_type] => utility
[patent_app_number] => 17/588507
[patent_app_country] => US
[patent_app_date] => 2022-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10962
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17588507
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/588507 | COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER | Jan 30, 2022 | Pending |